People: CryoPort Inc (CYRX.OB)

CYRX.OB on OTC BB

0.43USD
2:37pm EDT
Price Change (% chg)

$-0.02 (-4.45%)
Prev Close
$0.45
Open
$0.39
Day's High
$0.43
Day's Low
$0.39
Volume
254
Avg. Vol
32,526
52-wk High
$0.70
52-wk Low
$0.11

Search Stocks

Summary

Name Age Since Current Position

Stephen Wasserman

 66 2012 Independent Chairman of the Board

Jerrell Shelton

 67 2012 President, Chief Executive Officer, Director

Robert Stefanovich

 47 2012 Chief Financial Officer, Treasurer, Corporate Secretary

Steven Leatherman

 58 2012 Chief Commercial Officer

Adam Michelin

 2011 Independent Director

Karen Muller

 57 2011 Independent Director

Richard Rathmann

 51 2013 Independent Director

Don Markley

 IR Officer
» Insider Trading

Biographies

Name Description

Stephen Wasserman

 Mr. Stephen E. Wasserman is an Independent Chairman of the Board of CryoPort, Inc. He became a member of the Company’s Board on March 29, 2012 and serves as Chairman of the Board. Mr. Wasserman is a consultant primarily to healthcare related organizations through his company, Wasserman & Associates, and a private investor. From 1997 until retirement in 2006, he served as Group Vice President—Diagnostic Systems Products of Olympus America, Inc., a subsidiary of Tokyo based Olympus Corporation, where he was a member of the Global Management Committee for In Vitro Diagnostics. From 1994 to 1997 Mr. Wasserman was Chief Financial Officer of Datascope Corporation, formerly a NASDAQ listed manufacturer and global marketer of medical devices where he was President, Patient Monitoring Division from 1994 to 1996. Prior to Datascope, from 1989 to 1993, he served as Vice President of NY Blood Center Inc and General Manager of Melville Biologics, a subsidiary that manufactured biopharmaceutical products. He was a founder and Chairman of the NY Biotechnology Association from 1990 to 1994. From 1981 to 1989, Mr. Wasserman held senior management positions with Technicon Instruments Corp. (now part of Siemens Healthcare Diagnostics) in Tarrytown, NY. Mr. Wasserman is a Certified Public Accountant and earned a BBA from City College of New York, Baruch School of Business. In 2008 he earned the Certificate of Director Education from the National Association of Corporate Directors. Mr. Wasserman is a seasoned executive with 20 years experience global in vitro diagnostic and medical device companies in growth situations created by internal programs as well as business combinations. He has served on the board of Iris International, Inc. since April 2006.

Jerrell Shelton

 Mr. Jerrell W. Shelton is the President, Chief Executive Officer, Director of CryoPort, Inc. He served on the Board of Directors and standing committees of Solera Holdings, Inc. from April 2007 through November 2011. From June 2004 to May 2006, Mr. Shelton was the Chairman and CEO of Wellness, Inc., a provider of advanced, integrated hospital and clinical environments. Prior to that, he served as CEO of IBM’s WebFountain. From October 1998 to October 1999, Mr. Shelton was Chairman, President and CEO of NDC Holdings II, Inc. Between October 1996 and July 1998, he was President and CEO of Continental Graphics Holdings, Inc. And from October 1991 to July 1996, Mr. Shelton served as President and CEO of Thomson Business Information Group. Mr. Shelton has a B.S. in Business Administration from the University of Tennessee and an M.B.A. from Harvard University. Mr. Shelton currently serves on the Advisory Board of Directors and the Nominating and Stewardship committee of the Smithsonian Institution Libraries.

Robert Stefanovich

 Mr. Robert S. Stefanovich is Chief Financial Officer, Treasurer, Corporate Secretary of CryoPort Inc. He became Chief Financial Officer, Treasurer and Corporate Secretary for the Company on June 27, 2011 following the Company’s filing of its Form 10–K for the fiscal year ended March 31, 2011. On June 15, 2012, Mr. Stefanovich was appointed Principal Executive Officer. From November 2007 through March 2011, Mr. Stefanovich served as Chief Financial Officer of Novalar Pharmaceuticals, Inc., a venture-backed specialty pharmaceutical company. Prior to that, he held several senior positions, including interim Chief Financial Officer of Xcorporeal, Inc., a publicly traded medical device company, Executive Vice President and Chief Financial Officer of Artemis International Solutions Corporation, a publicly traded software company, Chief Financial Officer and Secretary of Aethlon Medical Inc., a publicly traded medical device company and Vice President of Administration at SAIC, a Fortune 500 company. Mr. Stefanovich served as a member of the Software Advisory Group and an Audit Manager with Price Waterhouse LLP’s (now PricewaterhouseCoopers) hi-tech practice in San Jose, CA and Frankfurt, Germany. He serves as a board member of Project InVision International, a provider of business performance improvement solutions. He received his Masters of Business Administration and Engineering from University of Darmstadt, Germany.

Steven Leatherman

 Mr. Steven L. Leatherman is Chief Commercial Officer of Cryoport, Inc., since April 2, 2012. Mr. Leatherman has 30 years of experience in sales and marketing, and operations management in the healthcare industry. Prior to joining the Company, Mr. Leatherman was Vice President of Global Surgical Supplies for Ansell Sandel Medical Solutions. From 2008 to 2011, Mr. Leatherman served as President of Sandel Medical Industries, a in healthcare safety solutions. From 2007 to 2008, he was general manager of Microflex, a division of BarrierSafe Solutions. Prior to that, he held several senior positions, including Director of Marketing for Bausch & Lomb, Surgical Division; Vice President of Marketing for Carl Zeiss Surgical, Inc.; Vice President, International Marketing for Terumo Heart, Inc. Mr. Leatherman has a Bachelor’s Degree in Biology from the University of Nevada, and a Master’s in Business Administration from the University of Phoenix.

Adam Michelin

 Mr. Adam M. Michelin is Independent Director of CryoPort Inc. Mr. Michelin is the Chief Executive Officer of OWS Products, LLC a position he has held since January 2011. Mr. Michelin has held several executive leadership positions including, President and Chief Executive Officer of Redux Holdings, Inc., a position he held for 6 years, Chief Executive Officer of Enterprise Group for 3 years, Chief Executive Officer for Phoenix Advisory Group for 5 years, Principal of Kibel Green, Inc., a position he held for 11 years prior to joining Enterprise Group, and Partner of KPMG LLP for 10 years. Mr. Michelin served on the board of Naturade Inc. between August 2006 and June 2008. Mr. Michelin has 30 years of practice in the areas of executive leadership and operations and is experienced in evaluating, structuring and implementing solutions for companies in operational and/or financial crisis. Mr. Michelin received his Juris Doctorate from the University of West Los Angeles and his Bachelor of Science from Tri State University.

Karen Muller

 Ms. Karen M. Muller is an Independent Director of CryoPort, Inc., since May 25, 2011. Ms. Muller is a corporate attorney who has been in private practice since May 2008. From August 2006 to January 2008, Ms. Muller was a member of the Board of Directors of, and a consultant to, Naturade, Inc., a publicly traded company in the neutraceutical industry. From November 2004 to August 2006, Ms. Muller was the co-owner of Cerius Interim Executive Solutions, which delivers interim executive management solutions to small and medium businesses. While at Cerius, Ms. Muller led its business development efforts. Prior to Cerius, from June 2003 to November 2004, Ms. Muller was managing director of Capital Asset Advisors, LLC, which provides investment banking and financial advisory services to middle market companies. From 1999 to 2003 Ms. Muller served as General Counsel and Chief Administrative Officer to Epoch Internet, one of the private internet service providers. Ms. Muller was a managing director and deputy general counsel for Lehman Brothers, Inc. (1988 to 1999) and a corporate attorney with the Wall Street law firm Cahill Gordon & Reindel (most of 1981 to 1988). Ms. Muller earned her Bachelor of Arts degree from Hunter College in 1978 and her Juris Doctor degree from Fordham University School of Law in 1981. Ms. Muller is a Director Emeritus for The Forum for Corporate Directors in Orange County, California.

Richard Rathmann

 Mr. Richard G. Rathmann has been appointed as Independent Director of CryoPort Inc., effective March 28, 2013. He served for the past eighteen years as a director of various for-profit and non-profit companies. Mr. Rathmann is the manager of GBR Investments, LLC since 2005 and has served as the Executive Director of the Rathmann Family Foundation since 2002. Mr. Rathmann received his bachelor’s degree from the University of Colorado and his juris doctor degree from Boston College Law School. Mr. Rathmann currently serves on the board of directors of PIN Pharma, the Rathmann Family Foundation, and Cellerant Therapeutics, where he served as Chairman from 2007 to 2012 and currently serves on the Audit Committee and as Chair of the Compensation Committee. Early in his career, he was an Assistant United States Attorney in the Central District of California (Los Angeles).

Don Markley

Basic Compensation

Name Fiscal Year Total

Stephen Wasserman

 --

Jerrell Shelton

 --

Robert Stefanovich

 306,820

Steven Leatherman

 --

Adam Michelin

 --

Karen Muller

 --

Richard Rathmann

 --

Don Markley

 --
As Of 30 Mar 2012

Insider Trading

Name Shares Traded Price

SHELTON JERRELL WILSON

 500,000 $0.20

MICHELIN ADAM M

 30,000 $0.55
» Full list on Insider Trading
Search Stocks